Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphocele × Octreotide × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasms 1 Lymphocele 1 Diarrhea 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03791736 2022-07-28

SANDOSTATINE

Institut Cancerologie de l'Ouest

Phase NA Terminated

Breast Neoplasms, Lymphocele

Data powered by HemOnc (CC BY 4.0) Colophon ⚡